
Med device task guide for UK conformity post-Brexit
Actions manufacturers can build into their regulatory planning as UK nears new regime
As the medical device industry prepares to enforce new rules post-Brexit, Maetrics, a global life sciences consulting firm, unveiled a
Manufacturers, who are working diligently to stay within the rules laid out by both the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR), need to also be mindful of the fact that businesses that have products on the UK market will need to follow the rules presented under this new leadership. It’s worth noting that that these companies have additional time—the EU MDR date has been pushed to May 2021.
For efficiency purposes, one of the initial priorities for impacted companies will be to track the commonalities between these EU and UK regulations. They should monitor developments as the situation progresses.
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.





